Skip header and navigation

Narrow By

   MORE

94 records – page 2 of 5.

COVID-19 vaccine and cancer : third doses

https://libcat.nshealth.ca/en/permalink/chpams37496
Nova Scotia Health Authority. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2021.
Pamphlet Number
4009
Available Online
View Pamphlet
As a person living with cancer, you may have questions about whether you will need a third dose of the COVID-19 vaccine. All vaccinations should only be considered after careful assessment of the risks and benefits. This pamphlet explains whether you will need a third dose of COVID-19 vaccine if you have had 2 doses of COVID-19 vaccine. Talk to your cancer care team if you have questions about the vaccine, boosters, and your unique situation.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
COVID-19 Vaccines
Neoplasms
Subjects (LCSH)
COVID-19 (Disease)
Vaccines
Cancer
Specialty
Cancer Care
Abstract
As a person living with cancer, you may have questions about whether you will need a third dose of the COVID-19 vaccine. All vaccinations should only be considered after careful assessment of the risks and benefits. This pamphlet explains whether you will need a third dose of COVID-19 vaccine if you have had 2 doses of COVID-19 vaccine. Talk to your cancer care team if you have questions about the vaccine, boosters, and your unique situation.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program; Approved by: Nova Scotia Health Cancer Patient Education Committee
Pamphlet Number
4009
Less detail

Dalteparin (Fragmin) to prevent clotting during hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35807
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1760
Available Online
View Pamphlet
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Dalteparin
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Blood--coagulation
Specialty
Nephrology
Abstract
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1760
Less detail

Déclenchement artificiel du travail et maturation cervicale au moyen de comprimés oraux de misoprostol (prostaglandine E1) (Cytotec)

https://libcat.nshealth.ca/en/permalink/chpams35880
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1816
Available Online
View Pamphlet
Le misoprostol est une pilule qui contient un médicament appelé prostaglandine E1. La prostaglandine E1 assouplit le col de l’utérus pour le préparer au travail et déclencher des contractions. Cytotec® est le nom de marque de ce médicament. Le présent dépliant explique à quoi s'attendre si vous prenez du misoprostol, les complications possibles et quand informer un membre de votre équipe de soins de santé. ; This pamphlet is a French translation of "Induction of Labour and Cervical Ripening wit…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Alternate Title
Induction of labour and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec®)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Misoprostol
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Le misoprostol est une pilule qui contient un médicament appelé prostaglandine E1. La prostaglandine E1 assouplit le col de l’utérus pour le préparer au travail et déclencher des contractions. Cytotec® est le nom de marque de ce médicament. Le présent dépliant explique à quoi s'attendre si vous prenez du misoprostol, les complications possibles et quand informer un membre de votre équipe de soins de santé.
This pamphlet is a French translation of "Induction of Labour and Cervical Ripening with Oral Misoprostol (Prostaglandin E1) (Cytotec®)" pamphlet 1771. Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 softens the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol, and when you should notify a member of your health care team.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1816
Less detail

Déclenchement artificiel du travail et maturation cervicale au moyen d’un cathéter à ballonnet

https://libcat.nshealth.ca/en/permalink/chpams35878
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1814
Available Online
View Pamphlet
Un cathéter à ballonnet est un tube souple muni d’un petit ballonnet à l’extrémité. Le cathéter à ballonnet aide à préparer le col de votre utérus pour le travail (maturation cervicale ou du col). Le présent dépliant explique ce qui se passe quand le cathéter à ballonnet est inséré (mis en place), les complications possibles et quand appeler l’hôpital ou y revenir. ; This pamphlet is a French translation of "Induction of labour and cervical ripening with balloon catheter" pamphlet 1769. A ballo…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Alternate Title
Induction of labour and cervical ripening with balloon catheter
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Catheters
Subjects (LCSH)
Labor (Obstetrics)
Catheters
Specialty
Gynecology
Abstract
Un cathéter à ballonnet est un tube souple muni d’un petit ballonnet à l’extrémité. Le cathéter à ballonnet aide à préparer le col de votre utérus pour le travail (maturation cervicale ou du col). Le présent dépliant explique ce qui se passe quand le cathéter à ballonnet est inséré (mis en place), les complications possibles et quand appeler l’hôpital ou y revenir.
This pamphlet is a French translation of "Induction of labour and cervical ripening with balloon catheter" pamphlet 1769. A balloon catheter is a soft tube with a small balloon on the end. The balloon catheter helps to get your cervix ready for labour (cervical ripening). This pamphlet explains what will happen when the balloon catheter is inserted (put in), possible complications of a balloon catheter, and when you should call or return to the hospital.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1814
Less detail

Déclenchement artificiel du travail et maturation cervicale au moyen d’une insertion vaginale de dinoprostone (Cervidil)

https://libcat.nshealth.ca/en/permalink/chpams35879
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1815
Available Online
View Pamphlet
Cervidil® est un dispositif mince et plat, comme un tampon. Il contient un médicament appelé dinoprostone. La dinoprostone est comme une substance naturelle produite par votre corps. Elle assouplit le col de votre utérus pour le préparer au travail. Le présent dépliant explique à quoi vous attendre comme suite à l’utilisation d’une insertion vaginale Cervidil®, les complications possibles et quand appeler l’hôpital ou y retourner. ; This pamphlet is a French translation of "Induction of Labour …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Alternate Title
Induction of labour and cervical ripening with Dinoprostone vaginal insert (Cervidil®)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Dinoprostone
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Cervidil® est un dispositif mince et plat, comme un tampon. Il contient un médicament appelé dinoprostone. La dinoprostone est comme une substance naturelle produite par votre corps. Elle assouplit le col de votre utérus pour le préparer au travail. Le présent dépliant explique à quoi vous attendre comme suite à l’utilisation d’une insertion vaginale Cervidil®, les complications possibles et quand appeler l’hôpital ou y retourner.
This pamphlet is a French translation of "Induction of Labour and Cervical Ripening with Dinoprostone Vaginal Insert (Cervidil®)" pamphlet 1770. Cervidil® is a thin, flat insert, like a tampon. It contains medication called dinoprostone. Dinoprostone is like a natural substance made by your body. It softens your cervix to get it ready for labour. This pamphlet explains what to expect when you get Cervidil®, possible complications of Cervidil®, and when you should call or return to the hospital.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1815
Less detail
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
0112
Available Online
View Pamphlet
Depo-Provera is an injectable (given by needle) form of hormones similar to the natural progesterone made by your ovaries each month. It is used to prevent pregnancy. This pamphlet explains how Depo-Provera works, how well it works, how to get it, when it starts working, pros and cons, who should not take it, and certain things to remember when taking it. Depo-Provera will not protect you against sexually transmitted infections (STIs). A list of resources is provided if you have any questions. …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Medroxyprogesterone Acetate
Contraception - methods
Subjects (LCSH)
Medroxyprogesterone
Contraception
Abstract
Depo-Provera is an injectable (given by needle) form of hormones similar to the natural progesterone made by your ovaries each month. It is used to prevent pregnancy. This pamphlet explains how Depo-Provera works, how well it works, how to get it, when it starts working, pros and cons, who should not take it, and certain things to remember when taking it. Depo-Provera will not protect you against sexually transmitted infections (STIs). A list of resources is provided if you have any questions. The French version of this pamphlet 2016, "Depo-Provera", is also available.
Responsibility
Prepared by: Nova Scotia Women's Choice Clinic
Pamphlet Number
0112
Less detail
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2016
Available Online
View Pamphlet
Depo-Provera est un produit hormonal injectable similaire à la progestérone naturelle produite par les ovaires tous les mois. Il sert à prévenir les grossesses. Le dépliant explique comment Depo-Provera travaille, quelle est son efficacité, comment se le procurer, quand il commence à agir, quels sont les avantages et les désavantages de prendre Depo-Provera, quelles sont les personnes qui ne devraient pas prendre ce produit hormonal et quelles sont les choses à ne pas oublier quand vous le pren…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Medroxyprogesterone Acetate
Contraception - methods
Subjects (LCSH)
Medroxyprogesterone
Contraception
Abstract
Depo-Provera est un produit hormonal injectable similaire à la progestérone naturelle produite par les ovaires tous les mois. Il sert à prévenir les grossesses. Le dépliant explique comment Depo-Provera travaille, quelle est son efficacité, comment se le procurer, quand il commence à agir, quels sont les avantages et les désavantages de prendre Depo-Provera, quelles sont les personnes qui ne devraient pas prendre ce produit hormonal et quelles sont les choses à ne pas oublier quand vous le prenez Depo-Provera ne vous protège pas contre les infections transmissibles sexuellement. D’autres ressources sont mentionnées au cas où vous auriez des questions.
This is a French translation of the English pamphlet 0112, "Depo-Provera". Depo-Provera is an injectable (given by needle) form of hormones similar to the natural progesterone made by your ovaries each month. It is used to prevent pregnancy. This pamphlet explains how Depo-Provera works, how well it works, how to get it, when it starts working, pros and cons, who should not take it, and certain things to remember when taking it. Depo-Provera will not protect you against sexually transmitted infections (STIs). A list of resources is provided if you have any questions.
Responsibility
Prepared by: Nova Scotia Women's Choice Clinic
Pamphlet Number
2016
Less detail

Dialysis patients : being prepared for an emergency

https://libcat.nshealth.ca/en/permalink/chpams35535
Nova Scotia Health Authority. Community Dialysis. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1564
Available Online
View Pamphlet
This pamphlet provides instructions on what dialysis patients should do if an emergency prevents them from starting or finishing their dialysis treatment at home or attending an appointment for dialysis. It explains what precautions to take, who to contact in an emergency, and what medications to take, and provides answers to common questions. The French version of this pamphlet 1901, "Patients recevant de la dialyse : se préparer en cas d’urgence", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Community Dialysis
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - therapy
Dialysis
Subjects (LCSH)
Kidneys--Diseases--Treatment
Dialysis
Abstract
This pamphlet provides instructions on what dialysis patients should do if an emergency prevents them from starting or finishing their dialysis treatment at home or attending an appointment for dialysis. It explains what precautions to take, who to contact in an emergency, and what medications to take, and provides answers to common questions. The French version of this pamphlet 1901, "Patients recevant de la dialyse : se préparer en cas d’urgence", is also available.
Responsibility
Prepared by: Community Dialysis
Pamphlet Number
1564
Less detail

Dépistage du diabète après la grossesse

https://libcat.nshealth.ca/en/permalink/chpams38180
Nova Scotia Health Authority. The Diabetes Care Program of Nova Scotia. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2339
Available Online
View Pamphlet
Processus à suivre pour dépister le diabète après la grossesse. Les sujets sont les suivants : besoin ou non de passer un test de dépistage, meilleur moment pour le dépistage, pourquoi le dépistage est utile, ce qu’il faut faire si vous ne voulez pas passer un test de dépistage, tests administrés et raisons pour lesquelles l’épreuve d’hyperglycémie provoquée par voie orale et l’analyse de la glycémie à jeun sont très importantes, façon dont les dispositions liées à ces deux épreuves sont prises…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. The Diabetes Care Program of Nova Scotia
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([8] p.) : digital, PDF file
Subjects (MeSH)
Diabetes, Gestational
Glucose Tolerance Test
Subjects (LCSH)
Diabetes in pregnancy
Glucose tolerance tests
Abstract
Processus à suivre pour dépister le diabète après la grossesse. Les sujets sont les suivants : besoin ou non de passer un test de dépistage, meilleur moment pour le dépistage, pourquoi le dépistage est utile, ce qu’il faut faire si vous ne voulez pas passer un test de dépistage, tests administrés et raisons pour lesquelles l’épreuve d’hyperglycémie provoquée par voie orale et l’analyse de la glycémie à jeun sont très importantes, façon dont les dispositions liées à ces deux épreuves sont prises, choses à faire pour ne pas oublier un test et trouver le temps nécessaire. Comment se préparer à l’épreuve d’hyperglycémie provoquée par voie orale avec 75 g de glucose. Informations sur ce à quoi vous attendre si vous êtes diabétique (y compris sur la prévention ou la gestion du diabète) ainsi qu’après un résultat normal.
This is a French translation of the English pamphlet 2300, “Screening for Diabetes After Pregnancy". Instructions for screening for diabetes after pregnancy are given. Topics include: whether you should be screened, the best time to be screened, why screening is helpful, what to do if you do not want to be screened, what tests are used, why these two tests (OGTT, fasting plasma glucose) are so important, how testing is arranged, and how to remember and find time to book a test. Instructions for how to get ready for the 75-gram OGTT test is given. Information on what to expect if you have diabetes (including steps on preventing or managing diabetes) is listed. What to expect after a normal test result is also provided.
Responsibility
Prepared by: The Diabetes Care Program of Nova Scotia
Pamphlet Number
2339
Less detail

Expected death at home form and process

https://libcat.nshealth.ca/en/permalink/chpams35899
Nova Scotia Health Authority. The Nova Scotia Palliative Care Network. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1844
Available Online
View Pamphlet
This pamphlet explains the steps that health care providers must take when plans have been made for a home death. The Expected Death at Home (EDAH) form summarizes the important information required to facilitate a peaceful and respectful home death. The form should be completed by a health care provider in discussion with the client/their delegate/their statutory decision-maker. What to do once the form has been completed and how to submit the form are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. The Nova Scotia Palliative Care Network
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Death and dying
Subjects (LCSH)
Death
Specialty
Palliative Care
Abstract
This pamphlet explains the steps that health care providers must take when plans have been made for a home death. The Expected Death at Home (EDAH) form summarizes the important information required to facilitate a peaceful and respectful home death. The form should be completed by a health care provider in discussion with the client/their delegate/their statutory decision-maker. What to do once the form has been completed and how to submit the form are included.
Notes
Previous title: Expected death at home form and process : information for health care providers
Responsibility
Prepared by: The Nova Scotia Health Palliative Care Network
Pamphlet Number
1844
Less detail

Finding a living kidney donor

https://libcat.nshealth.ca/en/permalink/chpams37567
Nova Scotia Health Authority. Multi-Organ Transplant Program. Living Kidney Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2271
Available Online
View Pamphlet
It can be hard to reach out to possible living donors. You may feel many emotions. This is normal. This pamphlet expalins the benefits of a kidney transplant from a living donor, how to find a living donor, who you should ask to be a donor, and what will happen when a person says they may be interested in being your living kidney donor. Contact information for Atlantic Canada Living Kidney Donation Programs is provided. Resources are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Multi-Organ Transplant Program. Living Kidney Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Kidney transplantation
Subjects (LCSH)
Kidneys--Transplantation
Specialty
Nephrology
Abstract
It can be hard to reach out to possible living donors. You may feel many emotions. This is normal. This pamphlet expalins the benefits of a kidney transplant from a living donor, how to find a living donor, who you should ask to be a donor, and what will happen when a person says they may be interested in being your living kidney donor. Contact information for Atlantic Canada Living Kidney Donation Programs is provided. Resources are included.
Responsibility
Prepared by: MOTP Living Kidney Program
Pamphlet Number
2271
Less detail

Finding health information online

https://libcat.nshealth.ca/en/permalink/chpams34533
Nova Scotia Health Authority. Library Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
0228
Available Online
View Pamphlet
Many people look for health information online. Using Google may give you lots of information, but it may not be the best information. The quality of information online varies. This pamphlet includes questions to ask about health-related websites, things to think about, and good starting points for online health information. The internet can be helpful, but it should never replace talking to your health care providers. They are the experts.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Library Services
Alternate Title
Finding health information on the web
Finding health information on the internet
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.): digital, PDF file
Subjects (MeSH)
Health Promotion
Consumer Health Information
Subjects (LCSH)
Patient education
Mass media in health education
Specialty
Hospitals
Abstract
Many people look for health information online. Using Google may give you lots of information, but it may not be the best information. The quality of information online varies. This pamphlet includes questions to ask about health-related websites, things to think about, and good starting points for online health information. The internet can be helpful, but it should never replace talking to your health care providers. They are the experts.
Notes
Previous title: Health information on the Internet
Responsibility
Prepared by: Nova Scotia Health Library Services
Pamphlet Number
0228
Less detail

The 'flu shot' : information for cancer patients, survivors and family members

https://libcat.nshealth.ca/en/permalink/chpams37359
Nova Scotia Health. Cancer Care Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2023.
Pamphlet Number
0031
Available Online
View Pamphlet
Patients currently on treatment for cancer should have the flu shot with an inactive (not live) vaccine. They should not have live vaccines, like the nasal spray flu vaccine. This pamphlet explains whether the flu shot will protect you from getting the flu, when flu season is, when you should have the flu shot, and what else you can do to protect yourself. It also gives a list of flu symptoms and explains what to do if you have symptoms. Websites for more information are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Influenza Vaccines
Neoplasms - therapy
Subjects (LCSH)
Cancer--Patients
Influenza vaccines
Specialty
Cancer Care
Abstract
Patients currently on treatment for cancer should have the flu shot with an inactive (not live) vaccine. They should not have live vaccines, like the nasal spray flu vaccine. This pamphlet explains whether the flu shot will protect you from getting the flu, when flu season is, when you should have the flu shot, and what else you can do to protect yourself. It also gives a list of flu symptoms and explains what to do if you have symptoms. Websites for more information are listed.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
0031
Less detail

Foods high in potassium

https://libcat.nshealth.ca/en/permalink/chpams35108
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
0610
Available Online
View Pamphlet
All fruits and vegetables have potassium. This pamphlet provides a list of foods that are high in potassium. If you have high blood potassium levels, you should avoid these foods. If you have low blood potassium levels, you should choose more of these foods daily. The French version of this pamphlet 2181, "Aliments riches en potassium," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Potassium Deficiency
Potassium, Dietary
Subjects (LCSH)
High-potassium diet
Potassium deficiency diseases
Specialty
Food and nutrition
Abstract
All fruits and vegetables have potassium. This pamphlet provides a list of foods that are high in potassium. If you have high blood potassium levels, you should avoid these foods. If you have low blood potassium levels, you should choose more of these foods daily. The French version of this pamphlet 2181, "Aliments riches en potassium," is also available.
Responsibility
Prepared by: Nutrition and Food Services
Pamphlet Number
0610
Less detail

Harbour View Hospital Adult Day Program

https://libcat.nshealth.ca/en/permalink/chpams36637
Nova Scotia Health Authority. Harbour View Hospital. Adult Day Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2046
Available Online
View Pamphlet
Harbour View Hospital’s Adult Day Program supports participants’ physical, mental, social, spiritual, and recreational needs. It also gives respite for caregivers. Topics include: Program info, who should attend, what will happen at the Program, how to join, and contact info.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Harbour View Hospital. Adult Day Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Recreation Therapy
Respite Care
Subjects (LCSH)
Recreation therapy
Respite care
Abstract
Harbour View Hospital’s Adult Day Program supports participants’ physical, mental, social, spiritual, and recreational needs. It also gives respite for caregivers. Topics include: Program info, who should attend, what will happen at the Program, how to join, and contact info.
Responsibility
Prepared by: Harbour View Hospital Adult Day Program
Pamphlet Number
2046
Less detail

HDR brachytherapy for gynecological cancers

https://libcat.nshealth.ca/en/permalink/chpams37402
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2024.
Pamphlet Number
4069
Available Online
View Pamphlet
This pamphlet explains what to expect after HDR (high-dose-rate) brachytherapy treatment for gynecological cancer. Topics include how to care for yourself, possible side effects, and when you should go to the Emergency room.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Alternate Title
High dose rate brachytherapy for gynecological cancers
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (]2] p.) : digital, PDF file
Subjects (MeSH)
Brachytherapy
Genital Neoplasms, Female - radiotherapy
Subjects (LCSH)
Generative organs, Female--Cancer--Radiotherapy
Radioisotope brachytherapy
Specialty
Cancer Care
Abstract
This pamphlet explains what to expect after HDR (high-dose-rate) brachytherapy treatment for gynecological cancer. Topics include how to care for yourself, possible side effects, and when you should go to the Emergency room.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4069
Less detail

Hepatitis B vaccine and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36604
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1425
Available Online
View Pamphlet
The liver is an organ in your body that helps to break down and digest the food you eat, cleans your blood, and fights infection. Hepatitis B is a virus that attacks the liver. “Hepatitis” means swelling of the liver. Hepatitis B can cause serious liver problems, including liver damage, liver failure, and liver cancer. People with kidney disease who may need dialysis or a kidney transplant in the future, have a higher chance of getting Hepatitis B. The best way to prevent Hepatitis B is to get …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Hepatitis B - prevention & control
Kidney Diseases
Subjects (LCSH)
Hepatitis B vaccine
Kidneys--Diseases
Specialty
Nephrology
Abstract
The liver is an organ in your body that helps to break down and digest the food you eat, cleans your blood, and fights infection. Hepatitis B is a virus that attacks the liver. “Hepatitis” means swelling of the liver. Hepatitis B can cause serious liver problems, including liver damage, liver failure, and liver cancer. People with kidney disease who may need dialysis or a kidney transplant in the future, have a higher chance of getting Hepatitis B. The best way to prevent Hepatitis B is to get vaccinated. This pamphlet explains what the hepatitis B vaccine is, possible side effects, and who should not get the vaccine.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1425
Less detail

Induction of labour and cervical ripening with balloon catheter

https://libcat.nshealth.ca/en/permalink/chpams35819
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1769
Available Online
View Pamphlet
A balloon catheter is a soft tube with a small balloon on the end. The balloon catheter helps to get your cervix ready for labour (cervical ripening). This pamphlet explains what will happen when the balloon catheter is inserted (put in), possible complications of a balloon catheter, and when you should call or return to the hospital. The French version of this pamphlet 1814, "Déclenchement artificiel du travail et maturation cervicale au moyen d’un cathéter à ballonnet", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Alternate Title
Induction of labor and cervical ripening with balloon catheter
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Catheters
Subjects (LCSH)
Labor (Obstetrics)
Catheters
Specialty
Gynecology
Abstract
A balloon catheter is a soft tube with a small balloon on the end. The balloon catheter helps to get your cervix ready for labour (cervical ripening). This pamphlet explains what will happen when the balloon catheter is inserted (put in), possible complications of a balloon catheter, and when you should call or return to the hospital. The French version of this pamphlet 1814, "Déclenchement artificiel du travail et maturation cervicale au moyen d’un cathéter à ballonnet", is also available.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1769
Less detail

Induction of labour and cervical ripening with dinoprostone vaginal insert (Cervidil)

https://libcat.nshealth.ca/en/permalink/chpams35820
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1770
Available Online
View Pamphlet
Cervidil® is a thin, flat insert, like a tampon. It contains medication called dinoprostone. Dinoprostone is like a natural substance made by your body. It softens your cervix to get it ready for labour. This pamphlet explains what to expect when you get Cervidil®, possible complications of Cervidil®, and when you should call or return to the hospital. The French version of this pamphlet 1815, "Déclenchement artificiel du travail et maturation cervicale au moyen d’une insertion vaginale de dino…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Alternate Title
Induction of labor and cervical ripening with dinoprostone vaginal insert (Cervidil)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Dinoprostone
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Cervidil® is a thin, flat insert, like a tampon. It contains medication called dinoprostone. Dinoprostone is like a natural substance made by your body. It softens your cervix to get it ready for labour. This pamphlet explains what to expect when you get Cervidil®, possible complications of Cervidil®, and when you should call or return to the hospital. The French version of this pamphlet 1815, "Déclenchement artificiel du travail et maturation cervicale au moyen d’une insertion vaginale de dinoprostone (Cervidil®)", is also available.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1770
Less detail

Induction of labour and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec)

https://libcat.nshealth.ca/en/permalink/chpams35821
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1771
Available Online
View Pamphlet
Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 softens the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol, and when you should notify a member of your health care team. The French version of this pamphlet 1816, "Déclenchement artificiel du travail et maturation cervicale au moyen de c…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Alternate Title
Induction of labor and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Misoprostol
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 softens the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol, and when you should notify a member of your health care team. The French version of this pamphlet 1816, "Déclenchement artificiel du travail et maturation cervicale au moyen de comprimés oraux de misoprostol (prostaglandine E1) (Cytotec®)", is also available.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1771
Less detail

94 records – page 2 of 5.